Haselmeier Announces the Market Launch of JuniorSTAR® by Sanofi

(PresseBox) ( Zurich, Switzerland, )
The new and reusable half-unit insulin pen JuniorSTAR® is now available in Germany. It is suitable for all insulin types of Sanofi. It provides individual dosage, which can be corrected easily. Furthermore, it has a large display to ensure the correct dosage and is a lightweight companion during the day, especially for young people with diabetes.

"The launch of JuniorSTAR® marks another milestone of a long-term partnership with Sanofi. After the single unit pen TactiPen®, the portfolio is now completed by the half-unit pen JuniorSTAR®. The JuniorSTAR® delivers 1 to 30 units in steps of 0.5. Thanks to the close cooperation of both teams we were able to develop an excellent pen which meets the current very high quality requirements." explains Sandra de Haan, Director Project Management at Haselmeier and responsible project manager for the JuniorSTAR® project.

"The JuniorSTAR® expands our individual portfolio for people suffering from diabetes. This pen offers, especially young people with type 1 diabetes, a flexible and easy handling to lighten their lives with diabetes. The excellent and close cooperation with Haselmeier was an important part for the successful development of the JuniorSTAR® pen." explains Hamit Oualali, Global Device Manager for reusable pens at Sanofi.

This pen comes in red, blue and silver for more flexibility and easy differentiation of various insulin types.

The Chicago Athenaeum, Museum of Architecture and Design already honoured the JuniorSTAR® pen for its new and fully developed technology with the Good Design Award.

About Sanofi

Sanofi-Aventis Deutschland GmbH is a company of the Sanofi Group, a global healthcare leader, which discovers, develops and distributes therapeutic solutions to meet the patients' needs. Sanofi has its core strengths in the field of healthcare with seven growth platforms: diabetes solutions, vaccines, innovative medication, over-the-counter health care products, emerging markets, animal health and Genzyme.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.